Treatment Approach for Bulimia Nervosa
For adults with bulimia nervosa, the recommended treatment is a combination of eating disorder-focused cognitive-behavioral therapy (CBT) and a serotonin reuptake inhibitor, specifically fluoxetine 60 mg daily. 1
First-Line Treatment
- Eating disorder-focused cognitive-behavioral therapy (CBT) is the cornerstone psychological treatment for bulimia nervosa, focusing on normalizing eating behaviors and addressing psychological aspects like fear of weight gain and body image disturbance 1
- Fluoxetine at 60 mg/day is the recommended pharmacological treatment, administered in the morning, as this dose was statistically significantly superior to placebo in reducing the frequency of binge-eating and vomiting 2
- For some patients, it may be advisable to titrate up to the target dose of fluoxetine over several days to improve tolerability 2
- The combination of CBT and medication has shown greater improvement in binge eating and depression symptoms than either treatment alone 3
Treatment Algorithm
Initial Assessment:
- Comprehensive evaluation including weighing the patient and quantifying eating and weight control behaviors (frequency, intensity, time spent on binge eating, purging, exercise) 1
- Identify co-occurring psychiatric disorders which are common in bulimia nervosa 1
- Physical examination including vital signs, height, weight, BMI, and signs of purging behaviors 1
- Laboratory assessment including complete blood count, comprehensive metabolic panel, electrolytes, liver enzymes, and renal function tests 1
- Electrocardiogram for patients with severe purging behavior 1
Treatment Implementation:
Special Populations:
Multidisciplinary Team Approach
- Treatment should be delivered by a coordinated multidisciplinary team incorporating medical, psychiatric, psychological, and nutritional expertise 4
- The team typically includes:
Treatment Efficacy and Duration
- Remission rates are approximately 49% for combined therapy versus 36% for psychological treatment alone and 23% for antidepressants alone 5
- Systematic evaluation has demonstrated benefit of continuing fluoxetine 60 mg/day for up to 52 weeks in patients who responded during an 8-week acute treatment phase 2
- Patients should be periodically reassessed to determine the need for maintenance treatment 2
Common Pitfalls and Considerations
- Dropout rates tend to be higher for medication alone compared to psychotherapy alone, suggesting psychotherapy may be more acceptable to patients 5
- When antidepressants are combined with psychological treatments, the acceptability of the latter may be significantly reduced 5
- Fluoxetine doses above 60 mg/day have not been systematically studied in patients with bulimia and are not recommended 2
- Technology-based interventions, including guided computer-based interventions and videoconferencing, show promise for treating bulimia nervosa and may help overcome barriers such as shame, stigma, and shortage of specialized providers 1, 4
Treatment Resistant Cases
- If a patient doesn't respond to first-line treatment, consider:
- Ensuring adequate dose and duration of both CBT and medication 2
- Evaluating for comorbid conditions that may be interfering with treatment response 1
- A two-stage medication intervention, trying a different antidepressant if the first is ineffective or poorly tolerated 3
- Intensifying the psychological approach or trying interpersonal therapy as an alternative 6
Despite decades of treatment development, a sizable proportion of individuals with bulimia nervosa do not respond to current evidence-based treatments, highlighting the need for continued research and development of new approaches 7.